Research Article
Analysis of the Distribution and Antibiotic Resistance of Pathogens Causing Infections in Hospitals from 2017 to 2019
Table 15
Analysis of multiple drug resistance rate of ESBLs-ECO in 2017.
| | Drugs | Drug resistance rate (%) |
| ESBLs-ECO | Ertapenem | 0 | | Piperacillin-tazobactam | 0 | | Imipenem | 0 | | ASmikacin | 2.2 | | Nitrofurantoin | 3 | | Cefoperazone-sulbactam | 6.4 | | Fosfomycin | 12.3 | | Tobramycin | 17.5 | | Cefepime | 32.9 | | Gentamicin | 41.1 | | Ceftazidime | 43.4 | | Cotrimoxazole | 53.9 | | Aztreonam | 66.3 | | Ampicillin-sulbactam | 66.8 | | Levofloxacin | 71.6 | | Ciprofloxacin | 75.8 | | Ampicillin | 99.3 | | Ceftriaxone | 99.5 |
|
|